The RUNX1 Research Program (RRP) is the only foundation globally dedicated to supporting patients with RUNX1-Familial Platelet Disorder (RUNX1-FPD), which is a rare inherited disease that can lead to serious health issues, including blood cancers. Through research, education, and advocacy, RRP aims to improve the lives of those affected by this condition and contribute to finding a cure.
2016
81-3557785
$807.4 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Stay updated with our 2024 events designed for patients, families, and researchers.
A platform for RUNX1-FPD patients to connect and share information.
Review the latest impact report highlighting RRP's achievements and ongoing efforts.
Overall Score
46
40
/100
Program Expense Ratio
86.94%
18
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.225
14
/20
Working Capital Ratio
0.2172
4
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 670.7K | 100.00% |
Program Services | 0 | 0.00% |
Investment Income | 0 | 0.00% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 670.7K | 100.00% |
Med Research
Medical Research Funding - Single OrgMed Research
Medical Research Funding - Single OrgMed Research
Medical Research Funding - Single OrgMed Research
Medical Research Funding - Single OrgMed Research
Medical Research Funding - Single Org